Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
RNAC holding history
Cartesian Therapeutics, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,807
- Value
- $216.8K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,807 | $216.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 20,807 | $128.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 20,807 | $150.0K | <0.1% | −1,359−6.1% | Reduced | Holders |
| Q3 2025 | 22,166 | $226.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 22,166 | $230.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 22,166 | $292.1K | 0.1% | −30,000−57.5% | Reduced | Holders |
| Q4 2024 | 52,166 | $934.3K | 0.3% | −27−0.1% | Reduced | Holders |
| Q3 2024 | 52,193 | $841.4K | 0.3% | −190,177−78.5% | Reduced | Holders |
| Q2 2024 | 242,370 | $6.55M | 2.0% | +242,370 | New | Holders |